1438 - Central Nervous System Involvement in Chronic Lymphocytic Leukemia: An International Retrospective Study by ERIC, the European Research Initiative on CLL

Primary Author / Presenter(s)

TC

Thomas Chatzikonstantinou, MD

Research Associate
Institute of Applied Biosciences, Centre for Research and Technology Hellas
Thessaloniki, Thessaloniki, Greece

Co-Author(s)

MK

Maya Koren-Michowitz, MD

Department of Hematology, Shamir Medical Center, Zerifin, Israel;Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel
Tel-Aviv, Tel Aviv, Israel
MM

Mariia Mikhaleva, MD

Medical Fellow
Medical Oncology, Dana-Farber Cancer Institute
Boston, Massachusetts, United States
CB

Christian Brieghel, PhD

Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark;Hematology Branch, Danish Cancer Institute
Copenhagen, Hovedstaden, Denmark
CP

Christina Papaggelou, MSc

Institute of Applied Biosciences, Centre for Research and Technology Hellas
Thessaloniki, Thessaloniki, Greece
EM

Eva Minga, MSc

Institute of Applied Biosciences, Centre for Research and Technology Hellas
Thessaloniki, Thessaloniki, Greece
CA

Celso Arrais, MD

Unifesp
Sao Paulo, Sao Paulo, Brazil
SB

Sotiria Besikli-Dimou, MD

Institute of Applied Biosciences, Centre for Research and Technology Hellas
Thessaloniki, Thessaloniki, Greece
AC

Amalia Cerutti, MD

Sanatorio Británico de Rosario, Santa Fé, Argentina
Santa Fe, Santa Fe, Argentina
Michael Doubek, MD, PhD

Department head
Department of Internal Medicine, Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic; Institute of Medical Genetics and Genomics, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Brno, Jihomoravsky kraj, Czech Republic
LE

Lisbeth Enggaard, MD

Department of Haematology, Copenhagen University Hospital
Copenhagen, Hovedstaden, Denmark
BE

Blanca Espinet, PhD

Head Molecular Cytogenetics Laboratory
Molecular Cytogenetics Laboratory, Pathology Department, Hospital del Mar and Translational Research on Hematological Neoplasms Group, Hospital del Mar Research Institute (IMIM)
Barcelona, Catalonia, Spain
JG

Jose Antonio Garcia Vela, MD

Hospital Universitario Puerta de Hierro Majadahonda
Madrid, Madrid, Spain
MG

Massimo Gentile, MD

Hematology Unit, Department of Onco-Hematology, AO of Cosenza;Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende
Cosenza, Calabria, Italy
EG

Eva Gimeno Vázquez, MD

Department of Hematology, Hospital del Mar
Barcelona, Catalonia, Spain
OG

Odit Gutwein, MD

Department of Hematology, Shamir Medical Center
Zerifin, Tel Aviv, Israel
Yair Herishanu, MD

Head of CLL Unit; Director, Hematology Clinic
Tel Aviv Sourasky Medical Center
Tel-Aviv, Tel Aviv, Israel
PJ

Paula Jablonowska, MD

Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University
Wroclaw, Dolnoslaskie, Poland
OJ

Ozren Jaksic, MD, PhD

Division of Hematology, Department of Medicine, University Hospital Dubrava, Medical School University of Zagreb
Zagreb, Grad Zagreb, Croatia
PJ

Par Josefsson, MD

Department of Haematology, Copenhagen University Hospital
Copenhagen, Hovedstaden, Denmark
EK

Elzbieta Kalicinska, MD, PhD

Assistant
Clinical Department of Hematology, Cell Therapies and Internal Diseases, Wroclaw Medical University
Wroclaw, Dolnoslaskie, Poland
Maria Kislova, MD

student
Department of Hematology, Oncology, and Chemotherapy S. P. Botkin's City Hospital Moscow Russia
Moscow, Moskva, Russia
EL

Enrico Lista, MD

UO Ematologia. Santa Chiara Hospital, APSS Trento
Trento, Trentino-Alto Adige, Italy
JM

Juan Marquet, N/A, MD

Physician
Hematology Department, Ramón y Cajal University Hospital
Madrid, Madrid, Spain
EM

Enrica Antonia Martino, MD

Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza
Cosenza, Calabria, Italy
CM

Ciaran McAuley, MD

Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia;Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia;Department of Diagnostic Haematology, Royal Melbourne Hospital, Melbourne, Victoria, Australia
Melbourne, Victoria, Australia
Maria Jose Mela Osorio, MD

Attending Physician and Clinical Research
FUNDALEU
Buenos Aires, Buenos Aires, Argentina
Riccardo Moia, MD, PhD

Postdoctoral Fellow
Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale, Novara
Novara, Piemonte, Italy
CM

Claudia Mosquera, MD

Hospital Universitario Puerta de Hierro Majadahonda
Madrid, Madrid, Spain
EN

Eugene A. Nikitin, MD

Head of department of hematology oncology and chemotherapy
Department of Hematology, Oncology, and Chemotherapy S. P. Botkin's City Hospital Moscow Russia
Moscow, Moskva, Russia
Miguel Arturo A. Pavlovsky, MD

Medical and Scientific Director
FUNDALEU
Buenos Aires, Buenos Aires, Argentina
Verena Pfister, MD

PhD student
Unifesp
Sao Paulo, Sao Paulo, Brazil
MS

Merve Savas, MD

Gazi University Medical Faculty
Ankara, Ankara, Turkey
Lydia Scarfò

Assistant Professor
Università Vita Salute and IRCCS Ospedale San Raffaele
Milano, Lombardia, Italy
MS

Matjaz Sever, MD

University Medical Centre, Ljubljana and Faculty of Medicine, University of Ljubljana
Ljubljana, Ljubljana, Slovenia
LS

Lev Shvidel, MD

Hematology, Director
Institute of Hematology, Kaplan Medical Center
Rehovot, Tel Aviv, Israel
MS

Martin Simkovic, MD

Consultant
4th Department of Internal Medicine-Hematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University, Hradec Kralove, Czech Republic
Hradec Kralove, Hlavni mesto Praha, Czech Republic
NS

Niki Stavroyianni, MD

Hematology Department and HCT Unit G. Papanicolaou Hospital Thessaloniki Greece
Thessaloniki, Thessaloniki, Greece
Andrea Visentin, MD, PhD

Assistant professor of Hematology
Division of Hematology, Department of Medicine-DIMED, University of Padova
Padova, Veneto, Italy
EW

Ewa Wasik-Szczepanek, MD

Dept. Hematooncology and Bone Marrow Transplantation, Medical University in Lublin
Lublin, Lubelskie, Poland
TW

Tomasz Wróbel, MD

Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University
Wroclaw, Dolnoslaskie, Poland
MY

Munci Yagci, MD

Gazi University Medical Faculty
Ankara, Ankara, Turkey
AC

Anastasia Chatzidimitriou, MD

Institute of Applied Biosciences, Centre for Research and Technology Hellas
Thessaloniki, Thessaloniki, Greece
Gianluca Gaidano, MD, PhD

Professor of Hematology
University of Eastern Piedmont, Maggiore Charity Hospital
Novara, Italy
Mary Ann Anderson, MBBS, FRACP, FRCPA, PHD

Consultant Haematologist
Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia;Division of Blood Cells and Blood Cancer, Walter and Eliza Hall Institute;Department of Medical Biology, The University of Melbourne
Melbourne, Victoria, Australia
Matthew S. Davids, MD, MMSc

Director, Clinical Research, Division of Lymphoma; Associate Professor of Medicine
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Jennifer R. Brown, MD, PhD

Director, CLL Center, and Institute Physician; Worthington Margaret Collette Professor of Medicine in the Field of Hematologic Oncology
Dana-Farber Cancer Institute, Harvard Medical School
Boston, Massachusetts, United States
Carsten U. Niemann, MD, PhD

Associate Professor
Rigshospitalet, Copenhagen University Hospital
Copenhagen, Hovedstaden, Denmark
Paolo Ghia, MD, PhD

Professor of Medical Oncology
Università Vita Salute and IRCCS Ospedale San Raffaele
Milano, Lombardia, Italy
Inhye E. Ahn, MD

Assistant Professor
Dana-Farber Cancer Institute
Boston, Massachusetts, United States